Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2019-04-30
Original SEC Filing: Click here

---

Webplus: SVA/20190430/6-K/2_EX-99.1/000.htm SEC Original: tv520180_ex99-1.htm
Sinovac Reports Unaudited Second Half of 2018 Financial Results and Files 2018 Annual Report on Form 20-F Second Half of 2018 Financial Highlights Ÿ Sales for the second half of 2018 were $107.2 million, which remains the same compared to $107.4 million in the prior year period. Revenue generated by Hepatitis A vaccine increased by $12.0 million compared to same

---

---

Webplus: SVA/20190430/6-K/1/000.htm SEC Original: tv520180_6k.htm

---

Company Info:

Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2019-04-30CIK: 0001084201, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
NO. 15 ZHI TONG ROAD,, ZHONGGUANCUN TECH PARK, CHANGPING DISTR.
BEIJING 102200